ArticleScientific reports2026

Anlotinib plus whole-brain radiotherapy for NSCLC brain metastases: a prospective, non-randomized, single-center cohort study.

Shuai Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.